Stay updated on Efficacy of Lebrikizumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Lebrikizumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Efficacy of Lebrikizumab in Atopic Dermatitis Clinical Trial page
- Check9 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 (added v3.4.3, removed v3.4.2).SummaryDifference0.0%

- Check17 days agoChange DetectedNo additions or deletions were detected on the page.SummaryDifference0.0%

- Check31 days agoChange DetectedOnly a site revision update from v3.4.1 to v3.4.2 is visible; no changes to study details, eligibility criteria, outcomes, or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page shows an update from revision v3.4.0 to v3.4.1. The visible content of the trial details remains unchanged.SummaryDifference0.0%

- Check45 days agoChange DetectedA publication reference for Lebrikizumab efficacy (Ann Allergy Asthma Immunol, 2025, online ahead of print) was added to Publications, and a related citation with Calleja LR was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded a glossary display option; updated QC metadata label to Last Update Submitted that Met QC Criteria and standardized capitalization for No FEAR Act Data; updated the page revision from v3.3.4 to v3.4.0.SummaryDifference0.1%

Stay in the know with updates to Efficacy of Lebrikizumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Lebrikizumab in Atopic Dermatitis Clinical Trial page.